App is temporarily unavailable
Description
港醫通應用程式提供遙距視像問診及跨境送藥服務
1. 視像問診：香港及國內用戶透過手機或電腦與香港專科醫生進行視診
2. 跨境送藥: 完成視診後，醫生處方的藥物會經可靠的物流團隊送到用戶手上
3. 專屬醫療服務：為每位客戶量身訂製專屬的個人醫療方案
4. 健康商城：精選多項由專業醫療機構提供的檢測及身體檢查服務 免責聲明：本系統只提供專業醫療意見，閣下作出治療前請先向醫療人員進一步查詢。
1. 視像問診：香港及國內用戶透過手機或電腦與香港專科醫生進行視診
2. 跨境送藥: 完成視診後，醫生處方的藥物會經可靠的物流團隊送到用戶手上
3. 專屬醫療服務：為每位客戶量身訂製專屬的個人醫療方案
4. 健康商城：精選多項由專業醫療機構提供的檢測及身體檢查服務 免責聲明：本系統只提供專業醫療意見，閣下作出治療前請先向醫療人員進一步查詢。
Screenshots
港醫通 FAQ
-
Is 港醫通 free?
Yes, 港醫通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 港醫通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 港醫通 cost?
港醫通 is free.
-
What is 港醫通 revenue?
To get estimated revenue of 港醫通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Romania yet.
Ratings History
港醫通 Reviews
No Reviews in Romania
App doesn't have any reviews in Romania yet.
港醫通 Installs
Last 30 days
港醫通 Revenue
Last 30 days港醫通 Revenue and Downloads
Gain valuable insights into 港醫通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- HK DOCTORS DIGITAL NETWORK
- Languages
- Recent release
- 1.2.5 (1 year ago )
- Released on
- Mar 10, 2023 (1 year ago )
- Also available in
- Hong Kong SAR China, Pakistan, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, India, Poland, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, United States, South Africa, Denmark, Argentina, Austria, Australia, Azerbaijan, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Italy, Dominican Republic, Algeria, Ecuador, Egypt, Spain, Finland, France, Greece, Hungary, Indonesia, Ireland, Israel, United Arab Emirates
- Last Updated
- 1 year ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.